Novartis

Ljubljana – The Swiss pharma giant Novartis continued to invest in its R&D and production capacities in Slovenia through its subsidiaries Lek, Sandoz and Novartis Pharma Services last year. Despite the Covid-19 epidemic, it invested EUR 204 million in the country, show figures presented on Tuesday.

For over one year the Novartis affair has fueled constant political tensions and it will be a central issue in the forthcoming general election, which is to be held by October at latest.

To Vima on Sunday reported yesterday that Corruption Prosecutor Eleni Touloupaki (photo) has told the Judicial Council that she expects the case to be wrapped up within the next six months.